These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37147348)

  • 21. SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis.
    Nguyen NN; Nguyen YN; Hoang VT; Million M; Gautret P
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.
    Arabi M; Al-Najjar Y; Sharma O; Kamal I; Javed A; Gohil HS; Paul P; Al-Khalifa AM; Laws S; Zakaria D
    BMC Infect Dis; 2023 Jun; 23(1):432. PubMed ID: 37365490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cluster of SARS-CoV-2 Gamma Variant Infections, Parintins, Brazil, March 2021.
    da Silva JF; Esteves RJ; Siza C; Soares EP; Ramos TC; Campelo EC; da Costa CF; de Alencar LC; Cavalcante RP; Florêncio CR; Mattos TP; Bonecini-Almeida MG; Silva-Flannery L; Marston BJ; Morgan J; Plucinski M; Naveca F;
    Emerg Infect Dis; 2022 Jan; 28(1):262-264. PubMed ID: 34856111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
    Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
    Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.
    Monteón V; León-Pérez F; Ancona-León JG; Gutiérrez-Torres G
    Salud Publica Mex; 2023 Dec; 66(1, ene-feb):14-16. PubMed ID: 38065105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological Surveillance Reveals the Rise and Establishment of the Omicron SARS-CoV-2 Variant in Brazil.
    Silva JDP; Lima AB; Alvim LB; Malta FSV; Mendonça CPTB; Carvalho AHB; Rios JSH; Fonseca PLC; Queiroz DC; Santos LCGAE; Ferreira ACS; Souza RP; Aguiar RS; Zauli DAG
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
    Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
    Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Al-Otaiby M; Krissaane I; Al Seraihi A; Alshenaifi J; Qahtani MH; Aljeri T; Zaatari E; Hassanain M; Algwizani A; Albarrag A; Al-Mozaini M; Alabdulaali M
    Int J Infect Dis; 2022 Sep; 122():758-766. PubMed ID: 35840098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals.
    Dai YC; Lin YC; Ching LL; Tsai JJ; Ishikawa K; Tsai WY; Chen JJ; Nerurkar VR; Wang WK
    Microbiol Spectr; 2023 Aug; 11(4):e0408122. PubMed ID: 37428104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of Cellular Immunity and IFN-γ Concentration in Preventing SARS-CoV-2 Infection and Reinfection: A Cohort Study.
    Primorac D; Brlek P; Pavelić ES; Mešić J; Glavaš Weinberger D; Matišić V; Molnar V; Srića S; Zadro R
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants.
    Kubale J; Gleason C; Carreño JM; Srivastava K; Singh G; ; Gordon A; Krammer F; Simon V
    mBio; 2022 Oct; 13(5):e0178422. PubMed ID: 35997286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 reinfections in the pediatric cohort-a single-center experience.
    Arslan A; Sahbudak Bal Z; Erci E; Yıldırım Arslan S; Bilen NM; Avcu G; Çiçek C; Ozkinay F; Kurugol Z
    J Trop Pediatr; 2023 Dec; 70(1):. PubMed ID: 38150674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological Markers of SARS-CoV-2 Reinfection.
    Siddiqui SM; Bowman KA; Zhu AL; Fischinger S; Beger S; Maron JS; Bartsch YC; Atyeo C; Gorman MJ; Yanis A; Hultquist JF; Lorenzo-Redondo R; Ozer EA; Simons LM; Talj R; Rankin DA; Chapman L; Meade K; Steinhart J; Mullane S; Siebert S; Streeck H; Sabeti P; Halasa N; Musk ER; Barouch DH; Menon AS; Nilles EJ; Lauffenburger DA; Alter G
    mBio; 2022 Feb; 13(1):e0214121. PubMed ID: 35073738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
    Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
    Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron.
    Burkholz S; Rubsamen M; Blankenberg L; Carback RT; Mochly-Rosen D; Harris PE
    Commun Biol; 2023 Mar; 6(1):288. PubMed ID: 36934204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.
    Fintelman-Rodrigues N; da Silva APD; Dos Santos MC; Saraiva FB; Ferreira MA; Gesto J; Rodrigues DAS; Vale AM; de Azevedo IG; Soares VC; Jiang H; Tan H; Tschoeke DA; Sacramento CQ; Bozza FA; Morel CM; Bozza PT; Souza TML
    Emerg Infect Dis; 2021 May; 27(5):1446-1453. PubMed ID: 33797393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of Early Establishment of SARS-CoV-2 VOC Omicron Lineages in Minas Gerais, Brazil.
    de Menezes MT; Moreira FRR; Whittaker C; Santos FM; Queiroz DC; Geddes V; Fonseca PLC; de Jesus JG; Mendes-Oliveira F; Reis-Souza V; Santos B; Zauli DAG; de Lima AB; de Brito Mendonça C; Alvim LB; do Prado Silva J; Malta FSV; de Souza Ferreira AC; Faria NR; Sabino EC; Aguiar RS
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prediction of protection probability against Omicron BA.1, BA.4 and BA.5 variants in symptomatic infections with prototype strain based on neutralization antibody levels].
    Lu WY; Chen XH; Zheng N; Yu HJ
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(18):1429-1434. PubMed ID: 37150697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.